Beena Wood, a drug safety specialist and chief product officer at Qinecsa Solutions, says 2025 has seen a reality check in this regard. In a pharmacovigilance context, she notes. “The impressive organisations have stopped chasing shiny AI pilots and started investing in ‘boring’ foundations: data quality; standardisation; and governance,” she says. “They’re not deploying fancy agentic systems yet – but they’re positioned to succeed when they do.”
